A new trading day began on Friday, with SELLAS Life Sciences Group Inc (NASDAQ: SLS) stock price up 7.30% from the previous day of trading, before settling in for the closing price of $1.78. SLS’s price has ranged from $0.77 to $2.27 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 45.94%. Meanwhile, its annual earnings per share averaged 41.33%. With a float of $103.11 million, this company’s outstanding shares have now reached $105.30 million.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 2.08%, while institutional ownership is 25.57%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Here are SELLAS Life Sciences Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 1.64 million, which is a drop from its year-to-date volume of 2.51 million. As of the previous 9 days, the stock’s Stochastic %D was 28.21%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 69.02%, which indicates a significant decrease from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1265 in the past 14 days, which was lower than the 0.1336 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8209, while its 200-day Moving Average is $1.4210. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.9831. Second resistance stands at $2.0563. The third major resistance level sits at $2.1628. If the price goes on to break the first support level at $1.8034, it is likely to go to the next support level at $1.6969. Now, if the price goes above the second support level, the third support stands at $1.6237.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
With a market capitalization of 201.12 million, the company has a total of 105,297K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,880 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,600 K.
